QA: Kura Oncology Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2019_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc

  xvar xval
0 AssetsCurrent 181,197,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,182,000
4 LiabilitiesCurrent 13,615,000
5 LiabilitiesNoncurrent 7,779,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 92,634,536
11 remainder_Revenues 0
12 remainder_NetIncome 1,893,330
13 remainder_ComprehensiveNetIncome -62,228
  yvar yval
0 Assets 182,379,000
1 Liabilities 21,394,000
2 Expenses 92,634,536
3 Revenues 0
4 StockholdersEquity 160,985,000
5 NetIncome -90,741,206
6 ComprehensiveNetIncome -90,772,320
7 BaseVar 149,181,547
8 EconomicCapitalRatiobeforeLimitedLiability 2.55
9 EconomicCapitalRatio 3.39

Edgar->Model Mapping

Feature Distribution

Change over Time